Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
ALPS Medical Breakthroughs ETF SBIO
$31.65
-$0.29 (-0.90%)
На 18:01, 12 мая 2023
Ключевые показатели
-
Marketcap
0.00000000
-
week52high
35.51
-
week52low
23.58
-
Revenue
-
P/E TTM
0
-
Beta
0.00000000
-
EPS
0.00000000
-
Last Dividend
1.37900000
-
Next Earnings Date
07 мая 2023 г. в 02:35
Описание компании
The fund employs a "passive management" - or indexing - investment approach designed to track the performance of the underlying index. It will normally invest at least 80% of its net assets in securities that comprise the underlying index. The underlying index is comprised of small and mid-cap stocks of biotechnology companies that have one or more drugs in either Phase II or Phase III of the U.S. Food and Drug Administration clinical trials.
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Новостная лента
5 Best ETF Areas of April Up At Least 10%
Zacks Investment Research
02 мая 2023 г. в 09:08
April brings with it seasonal tailwinds for the equity world. Digital Assets, Sugar, Platinum, Biotech and Homebuilding were clear winners in the month.
ALPS' Biotech ETF SBIO Week's Top Performer
ETF Trends
24 апр 2023 г. в 17:48
In a somewhat surprising turn, biotech and life sciences-focused ETFs were the driving themes in the last week's top-performing ETFs, with the ALPS Medical Breakthroughs ETF (SBIO) leading the way with a 10% return.
Best ETF Areas of Last Week
Zacks Investment Research
24 апр 2023 г. в 14:28
Wall Street offered a flat performance last week. Biotech, platinum and home building were some of the areas that won last week.
Biotech ETFs' Performance Deserves A Look
ETF Trends
19 апр 2023 г. в 15:38
Biotech comes with a great many positive externalities for society, and can be a big positive for portfolios right now.
The 7 Best Biotech ETFs to Buy for Exposure to the Healthcare Sector
InvestorPlace
15 мар 2023 г. в 11:31
Amid the trying circumstances in the market right now, investors may be well served to target the best biotech ETFs to buy. Fundamentally, these exchange-traded funds benefit from permanent relevance.